Parkman Healthcare Partners LLC / ISI
Parkman Healthcare Partners LLC’s Ionis Pharmaceuticals Inc Position
Does Parkman Healthcare Partners LLC own Ionis Pharmaceuticals Inc (ISI)? Not currently — the last reported position was 161.7K shares worth $8M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$8M
Q2 2024
Shares
161.7K
% of Portfolio
+1.03%
Quarters Held
14
position exited
Position History ISI
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 161.7K | $8M | +1.03% |
| Q1 2024 | 141.5K | $6M | +0.75% |
| Q4 2023 | 211.4K | $11M | +1.51% |
| Q3 2023 | 159.5K | $7M | +1.33% |
| Q2 2023 | 153.1K | $6M | +1.09% |
| Q1 2023 | 151.2K | $5M | +1.17% |
| Q4 2022 | 141.1K | $5M | +1.42% |
| Q3 2022 | 241.9K | $11M | +3.04% |
| Q2 2022 | 174.3K | $6M | +2.38% |
| Q4 2021 | 80.2K | $2M | +0.54% |
| Q3 2021 | 136.4K | $5M | +1.16% |
| Q2 2021 | 136.4K | $5M | +1.19% |
| Q1 2021 | 105.8K | $5M | +1.10% |
| Q4 2020 | 75.4K | $4M | +1.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of ISI.